News
It’s a contentious issue. Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products.
It’s a contentious issue. Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products.
It’s a contentious issue. Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products.
The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with insurance, coverage remains uneven.
Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a ...
It’s a contentious issue. Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products.
Over the weekend of June 11–14, 2025, the NCAA Outdoor Track & Field Championships returned to Hayward Field for the fourth time since its reconstruction. Georgia captured the women’s national ...
Another name has joined the growing list of professional athletes caught in the crosshairs of sports betting investigations. Cleveland Guardians pitcher Luis Ortiz is the latest Major Leaguer ...
Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts.
It’s a contentious issue. Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results